Neuronetics, Inc. cash flow to debt ratio of -22.56% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Neuronetics, Inc.'s free cash flow has increased -34.77% from $-32.46M last year to $-21.18M, signaling increasing performance

Neuronetics, Inc.'s debt to equity ratio is 1.40, which means that the company's assets are unhealthy financed, signaling financial risk.

Neuronetics, Inc.'s debt has decreased relative to shareholder equity from 2.98 last year to 1.40 today, signaling strengthened financials

Neuronetics, Inc. has negative EBITDA, making leverage ratio unreliable

Neuronetics, Inc.'s interest coverage ratio is -2.67, which means that the company struggles to meet interest obligations, signaling financial risk.

Neuronetics, Inc.'s profit margin has increased (-66.38%) in the last year from -58.36% to -19.62%, signaling increasing performance

Neuronetics, Inc.'s short-term assets of $61.55M exceed its short-term liabilities of $30.52M

Neuronetics, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Neuronetics, Inc.'s return on equity of -150.56%, is lower than 15.00%, indicating bad performance

Neuronetics, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Neuronetics, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Neuronetics, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Neuronetics, Inc. has negative free cash flow, indicating cash burn

Neuronetics, Inc.'s yearly earnings has increased -10.78% since last year from $-43.71M to $-39.00M, signaling increasing performance

Neuronetics, Inc.'s yearly revenue has increased 99.17% since last year from $74.89M to $149.16M, signaling increasing performance

ROIC -21.10% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Neuronetics, Inc.'s 3-year revenue CAGR of 31.76% is positive, indicating growing revenue over the past 3 years

Neuronetics, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Neuronetics, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Neuronetics, Inc. has insufficient data to evaluate this check.

Neuronetics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Neuronetics, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Neuronetics, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Neuronetics, Inc. is overvalued relative to its fair value price of -20.20 based on Earnings Fair Value model

Neuronetics, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Neuronetics, Inc. has a price-to-book ratio of 7.16x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Neuronetics, Inc. has a price-to-sales ratio of 1.00x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue